FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/05/033360 [Registered on: 04/05/2021] Trial Registered Prospectively
Last Modified On: 03/05/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   To study the role of Eladi Kwatha with Sharkara and Madhu in atyadhik yonigata raktastrava with special reference to Abnormal uterine bleeding 
Scientific Title of Study   An open label single arm clinical study of Eladi Kwatha with Sharkara and Madhu in Yonipravaha with special reference to Abnormal Uterine Bleeding 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kalyani Mitalkumar Mahajan 
Designation  PG scholar 
Affiliation  SGAK Hospital Hadapsar Pune 411028 
Address  Sane Guruji Arogya kendra PG girls hostel, room no 222 Malwadi Hadapsar Pune
Deptartment of striroga prasutitantra Sumatibhai Shah Ayurved Mahavidyalaya Malawadi Hadapsar Pune 411028
Pune
MAHARASHTRA
411028
India 
Phone  08983460329  
Fax    
Email  mkrushna002@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Trupti Kalyan Gawade 
Designation  Assistant Professor 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  Deptartment of striroga evum prasutitantra Sumatibhai Shah Ayurved Mahavidyalaya Malawadi Hadapsar Pune 411028

Pune
MAHARASHTRA
411028
India 
Phone  9881840224  
Fax    
Email  truptigawade13@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Trupti Kalyan Gawade 
Designation  Assistant Professor 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  Deptartment of striroga prasutitantra Sumatibhai Shah Ayurved Mahavidyalaya Malawadi Hadapsar Pune 411028

Pune
MAHARASHTRA
411028
India 
Phone  9881840224  
Fax    
Email  truptigawade13@gmail.com  
 
Source of Monetary or Material Support  
Department of striroga and prasutitantra sane Guruji Arogya Kendra Hadapsar Pune 
 
Primary Sponsor  
Name  Kalyani Mitalkumar Mahajan 
Address  PG Girls Hostels, room no 222 Sane Guruji Arogya Kendra Malwadi Hadapsar Pune Department of striroga and prasutitantra sane Guruji Arogya Kendra Hadapsar Pune 411028 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kalyani Mitalkumar Mahajan  Sane Guruji Arogya Kendra  Department of striroga and prasutitantra Sane Guruji Arogya Kendra Malwadi Hadapsar Pune 411028
Pune
MAHARASHTRA 
8983460329

mkrushna002@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E349||Endocrine disorder, unspecified. Ayurveda Condition: Yonipravaha (Abnormal Uterine Bleeding),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Eladi Kwatha With Sharkara and Madhu   will be given 20ml four times a day for 5 days 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Patients between the age group 15-45 yrs
Both married and unmarried women
Patients having Abnormal Uterine Bleeding with excessive and prolonged menstrual bleeding
 
 
ExclusionCriteria 
Details  Patients taking anti coagulation therapy and having any coagulation
defect.
Patients with severe malnutrition and severe anemia (Hb ≤ 8 gm/dl).
Threatened, spontaneous or incomplete abortion/ectopic pregnancy,
trophoblastic diseases, placental abnormalities and Antepartum
Hemorrhage.
Patients with systemic diseases like uncontrolled D.M. and T.B.
History of documented vascular disease like coronary artery disease,
cerebrovascular disease or stroke, transient ischemic attack, peripheral
vascular disease and DVT.
Condition like endometrial cancer of cervix, etc.
Bleeding from Reproductive Track due to traumatic causes, motor vehicle
accident and IC 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the efficacy of Eladi Kwatha with Sharkara and Madhu in
Yonipravaha.
 
day 1 to day 5 of Abnormal uterine bleeding 
 
Secondary Outcome  
Outcome  TimePoints 
Adverse effect of drug Eladi Kwatha with Sharkara and Madhu will be
observed during clinical study, if any. 
18 months of study period 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/05/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not any 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

TITLE - An open label single arm clinical study of Eladi Kwatha with Sharkara and Madhu in Yonipravaha with special reference to abnormal uterine bleeding

Study design - an open label single arm clinical study

SAMPLE SIZE - 30

SAMPLING METHOD - Sequential Sampling


INCLUSION CLITERIA -Patients between the age group 15-45 yrs
                                       Both married and unmarried women
                                       Patients having Abnormal Uterine Bleeding with excessive and prolonged menstrual bleeding

EXCLUSION CLITERIA - Patients taking anti coagulation therapy and having any coagulation defect.
                                         Patients with severe malnutrition and severe anemia (Hb ≤ 8 gm/dl).
                                        Threatened, spontaneous or incomplete abortion/ectopic pregnancy,
                                         trophoblastic diseases, placental abnormalities and Antepartum Hemorrhage.
                                        Patients with systemic diseases like uncontrolled D.M. and T.B.
                                        History of documented vascular disease like coronary artery disease,
                                        cerebrovascular disease or stroke, transient ischemic attack, peripheral
                                        vascular disease and DVT.
                                        Condition like endometrial cancer of cervix, etc.
                                        Bleeding from Reproductive Track due to traumatic causes, motor vehicle
                                        accident and IC

WITHDRAWAL CLITERIA -  Patients not willing for further trial. 
                                          - If patient develops any adverse effect. 
                                          - If bleeding increases during trial.
 
Close